Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership27,131 shares
Latest Disclosed Value $ 806,062
Citigroup Inc ownership in TVTX / Travere Therapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 27,131 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $806,062 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 27,111 shares of Travere Therapeutics, Inc.. This represents a change in shares of 0.07% during the quarter. The current value of the position is $1,226,321 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (TVTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TVTX / Travere Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 27,131 20 0.07 806 -22.13 0.0002
2026-02-13 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 27,111 14,790 120.04 1,036 252.04 0.0005
2025-11-10 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 12,321 -55,232 -81.76 294 -70.57 0.0001
2025-08-11 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 67,553 -108,693 -61.67 1,000 -68.37 0.0005
2025-05-12 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 176,246 39,090 28.50 3,158 32.19 0.0016
2025-02-12 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 137,156 79,555 138.11 2,389 196.77 0.0014
2024-11-12 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 57,601 12,648 28.14 806 118.16 0.0005
2024-08-12 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 44,953 -462,080 -91.13 370 -90.56 0.0002
2024-05-10 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 507,033 294,970 139.10 3,909 105.09 0.0026
2024-02-09 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 212,063 -121,308 -36.39 1,906 -36.04 0.0013
2023-12-06 2023-09-30 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 333,371 67,909 25.58 2,980 -26.91 0.0022
2023-11-09 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 333,371 67,909 2,980 0.0022
2023-08-10 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 265,462 -96,609 -26.68 4,077 -49.93 0.0027
2023-05-11 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 362,071 216,863 149.35 8,143 166.69 0.0057
2023-02-09 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 145,208 -46,176 -24.13 3,054 -35.25 0.0024
2022-11-10 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 191,384 54,490 39.80 4,715 42.15 0.0034
2022-08-10 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 136,894 107,049 358.68 3,317 330.78 0.0025
2022-05-12 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 29,845 -114,539 -79.33 770 -82.82 0.0005
2022-02-10 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 144,384 -91,443 -38.78 4,482 -21.63 0.0024
2021-11-10 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 235,827 25,308 12.02 5,719 86.23 0.0034
2021-08-10 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 210,519 85,578 68.49 3,071 -1.57 0.0018
2021-05-13 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 124,941 112,971 943.78 3,120 857.06 0.0020
2021-02-11 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 11,970 7,370 160.22 326 283.53 0.0002
2020-11-12 2020-09-30 13F RETROPHIN COM 761299106 4,600 -27,214 -85.54 85 -86.92 0.0001
2020-08-12 2020-06-30 13F RETROPHIN COM 761299106 31,814 -2,876 -8.29 650 28.21 0.0005
2020-05-12 2020-03-31 13F RETROPHIN COM 761299106 34,690 19,327 125.80 507 132.57 0.0005
2020-02-12 2019-12-31 13F RETROPHIN COM 761299106 15,363 -112,692 -88.00 218 -85.31 0.0002
2019-11-08 2019-09-30 13F RETROPHIN COM 761299106 128,055 23,117 22.03 1,484 -29.63 0.0012
2019-08-12 2019-06-30 13F RETROPHIN COM 761299106 104,938 80,777 334.33 2,109 286.26 0.0017
2019-05-13 2019-03-31 13F RETROPHIN COM 761299106 24,161 -59,237 -71.03 546 -71.07 0.0005
2019-02-12 2018-12-31 13F RETROPHIN COM 761299106 83,398 58,641 236.87 1,887 165.40 0.0019
2018-11-13 2018-09-30 13F RETROPHIN COM 761299106 24,757 4,168 20.24 711 26.51 0.0006
2018-08-10 2018-06-30 13F RETROPHIN COM 761299106 20,589 14,826 257.26 562 335.66 0.0005
2018-05-11 2018-03-31 13F RETROPHIN COM 761299106 5,763 -33,221 -85.22 129 -84.31 0.0001
2018-02-12 2017-12-31 13F RETROPHIN COM 761299106 38,984 20,351 109.22 822 77.16 0.0007
2017-11-13 2017-09-30 13F RETROPHIN COM 761299106 18,633 -7,177 -27.81 464 -7.20 0.0004
2017-08-11 2017-06-30 13F RETROPHIN COM 761299106 25,810 5,082 24.52 500 30.55 0.0005
2017-05-12 2017-03-31 13F RETROPHIN COM 761299106 20,728 -85,642 -80.51 383 -80.97 0.0003
2017-02-10 2016-12-31 13F RETROPHIN COM 761299106 106,370 89,322 523.94 2,013 426.96 0.0018
2016-11-10 2016-09-30 13F RETROPHIN COM 761299106 17,048 9,714 132.45 382 191.60 0.0004
2016-08-12 2016-06-30 13F RETROPHIN COM 761299106 7,334 -23,905 -76.52 131 -69.32 0.0001
2016-05-13 2016-03-31 13F RETROPHIN COM 761299106 31,239 27,986 860.31 427 577.78 0.0005
2016-02-12 2015-12-31 13F RETROPHIN COM 761299106 3,253 -17,722 -84.49 63 -85.18 0.0001
2015-11-13 2015-09-30 13F RETROPHIN COM 761299106 20,975 16,474 366.01 425 185.23 0.0004
2015-08-13 2015-06-30 13F RETROPHIN COM 761299106 4,501 -467 -9.40 149 25.21 0.0001
2015-05-14 2015-03-31 13F RETROPHIN COM 761299106 4,968 -4,267 -46.20 119 5.31 0.0001
2015-02-17 2014-12-31 13F RETROPHIN COM 761299106 9,235 8,458 1,088.55 113 1,514.29 0.0001
2014-11-14 2014-09-30 13F RETROPHIN COM 761299106 777 418 116.43 7 75.00 0.0000
2014-08-14 2014-06-30 13F RETROPHIN COM 761299106 359 -1,640 -82.04 4 -90.70 0.0000
2014-05-15 2014-03-31 13F RETROPHIN COM 761299106 1,999 1,999 43 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-13 2021-03-31 13F TRAVERE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F TRAVERE THERAPEUTICS COM Call 100 0.00 3 50.00 n/a n/a n/a
2020-11-12 2020-09-30 13F RETROPHIN COM Call 100 0.00 2 0.00 n/a n/a n/a
2020-08-12 2020-06-30 13F RETROPHIN COM Call 100 0.00 2 100.00 n/a n/a n/a
2020-05-12 2020-03-31 13F RETROPHIN COM Call 100 -96.00 1 -97.22 n/a n/a n/a
2020-02-12 2019-12-31 13F RETROPHIN COM Call 2,500 0.00 36 24.14 n/a n/a n/a
2019-11-08 2019-09-30 13F RETROPHIN COM Call 2,500 29 n/a n/a n/a
2019-08-12 2019-06-30 13F RETROPHIN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-13 2019-03-31 13F RETROPHIN COM Call 1,200 -82.35 27 -82.47 n/a n/a n/a
2019-02-12 2018-12-31 13F RETROPHIN COM Call 6,800 6,700.00 154 5,033.33 n/a n/a n/a
2018-11-13 2018-09-30 13F RETROPHIN COM Call 100 3 n/a n/a n/a
2018-08-10 2018-06-30 13F RETROPHIN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-11 2018-03-31 13F RETROPHIN COM Call 2,000 -9.09 45 -2.17 n/a n/a n/a
2018-02-12 2017-12-31 13F RETROPHIN COM Call 2,200 -4.35 46 -19.30 n/a n/a n/a
2017-11-13 2017-09-30 13F RETROPHIN COM Call 2,300 0.00 57 26.67 n/a n/a n/a
2017-08-11 2017-06-30 13F RETROPHIN COM Call 2,300 -36.11 45 -31.82 n/a n/a n/a
2017-05-12 2017-03-31 13F RETROPHIN COM Call 3,600 -18.18 66 -20.48 n/a n/a n/a
2017-02-10 2016-12-31 13F RETROPHIN COM Call 4,400 2,100.00 83 1,975.00 n/a n/a n/a
2016-11-10 2016-09-30 13F RETROPHIN COM Call 200 4 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-12 2020-03-31 13F RETROPHIN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-12 2019-12-31 13F RETROPHIN COM Put 500 -98.48 7 -98.17 n/a n/a n/a
2019-11-08 2019-09-30 13F RETROPHIN COM Put 33,000 2.48 382 -40.96 n/a n/a n/a
2019-08-12 2019-06-30 13F RETROPHIN COM Put 32,200 1,010.34 647 880.30 n/a n/a n/a
2019-05-13 2019-03-31 13F RETROPHIN COM Put 2,900 3.57 66 4.76 n/a n/a n/a
2019-02-12 2018-12-31 13F RETROPHIN COM Put 2,800 -76.27 63 -81.42 n/a n/a n/a
2018-11-13 2018-09-30 13F RETROPHIN COM Put 11,800 18.00 339 24.18 n/a n/a n/a
2018-08-10 2018-06-30 13F RETROPHIN COM Put 10,000 273 n/a n/a n/a
2017-08-11 2017-06-30 13F RETROPHIN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-12 2017-03-31 13F RETROPHIN COM Put 1,500 400.00 28 366.67 n/a n/a n/a
2017-02-10 2016-12-31 13F RETROPHIN COM Put 300 6 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.